Successful Management of Severe Hyperhaemolysis with Combined Tocilizumab and Rituximab in Non-Transfusion-Dependent Thalassaemia: A Case Report.

Autor: El Afifi AM; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt., Saeed AM; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt., Fekry GH; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt., Mostafa MA; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt., Elmetwally RA; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt., Hamed IM; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt., Hussein AN; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt., Hasanien GM; Clinical Haematology and Oncology Unit, Department of Internal Medicine, Ain Shams University, Cairo, Egypt.

Publikováno v: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie [Transfus Med Hemother] 2022 Jun 30; Vol. 50 (1), pp. 66-70. Date of Electronic Publication: 2022 Jun 30 (Print Publication: 2023).